Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
$13.14
-3.0%
$13.60
$11.31
$20.72
$1.88BN/A384,426 shs267,142 shs
Celcuity Inc. stock logo
CELC
Celcuity
$12.11
-3.6%
$10.76
$7.58
$19.77
$458.56M0.37290,578 shs115,413 shs
National HealthCare Co. stock logo
NHC
National HealthCare
$103.10
-1.4%
$99.18
$89.14
$138.49
$1.59B0.5555,541 shs55,936 shs
Progyny, Inc. stock logo
PGNY
Progyny
$21.03
-2.4%
$21.96
$13.39
$30.42
$1.80B1.321.71 million shs819,289 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
+1.66%-7.95%-6.88%-2.83%+1,353,999,900.00%
Celcuity Inc. stock logo
CELC
Celcuity
+0.56%+6.62%+16.08%+25.22%-16.27%
National HealthCare Co. stock logo
NHC
National HealthCare
-0.13%-0.83%-0.79%+11.69%+0.92%
Progyny, Inc. stock logo
PGNY
Progyny
-0.65%+0.89%-0.60%+5.84%-22.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
3.3016 of 5 stars
3.50.00.00.02.40.03.1
Celcuity Inc. stock logo
CELC
Celcuity
1.9278 of 5 stars
3.60.00.00.03.22.50.0
National HealthCare Co. stock logo
NHC
National HealthCare
N/AN/AN/AN/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
1.6225 of 5 stars
2.21.00.00.02.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
3.00
Buy$20.6757.28% Upside
Celcuity Inc. stock logo
CELC
Celcuity
3.17
Buy$30.80154.34% Upside
National HealthCare Co. stock logo
NHC
National HealthCare
0.00
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
2.42
Hold$23.4511.53% Upside

Current Analyst Ratings Breakdown

Latest CELC, ARDT, PGNY, and NHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.00
5/19/2025
Celcuity Inc. stock logo
CELC
Celcuity
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$27.00 ➝ $27.00
5/15/2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.00
5/15/2025
Celcuity Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
5/9/2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $18.00
4/11/2025
Celcuity Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
4/9/2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$19.00 ➝ $18.00
4/1/2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.00
4/1/2025
Celcuity Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
$6.02B0.31N/AN/AN/A
Celcuity Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/A$5.48 per shareN/A
National HealthCare Co. stock logo
NHC
National HealthCare
$1.37B1.16$6.58 per share15.68$59.41 per share1.74
Progyny, Inc. stock logo
PGNY
Progyny
$1.21B1.49$0.59 per share35.58$5.77 per share3.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
$53.90M$1.638.066.70N/AN/AN/AN/A8/13/2025 (Estimated)
Celcuity Inc. stock logo
CELC
Celcuity
-$63.78M-$3.03N/AN/AN/AN/A-62.66%-39.78%8/13/2025 (Estimated)
National HealthCare Co. stock logo
NHC
National HealthCare
$66.80M$6.9212.92N/A10.03%6.87%4.68%N/A
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.5736.2632.352.395.03%11.36%7.87%8/5/2025 (Estimated)

Latest CELC, ARDT, PGNY, and NHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Celcuity Inc. stock logo
CELC
Celcuity
-$0.95-$0.86+$0.09-$0.86N/AN/A
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
5/6/2025Q1 2025
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion
3/31/2025Q4 2024
Celcuity Inc. stock logo
CELC
Celcuity
-$0.72-$0.85-$0.13-$0.85N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
N/AN/AN/AN/AN/A
Celcuity Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/AN/A
National HealthCare Co. stock logo
NHC
National HealthCare
$2.562.48%N/A36.99%10 Years
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A

Latest CELC, ARDT, PGNY, and NHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
National HealthCare Co. stock logo
NHC
National HealthCare
quarterly$0.642.7%6/30/20256/30/20258/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
0.78
1.91
1.78
Celcuity Inc. stock logo
CELC
Celcuity
0.65
10.35
10.36
National HealthCare Co. stock logo
NHC
National HealthCare
0.14
1.80
1.77
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.62
2.62

Institutional Ownership

CompanyInstitutional Ownership
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
N/A
Celcuity Inc. stock logo
CELC
Celcuity
63.33%
National HealthCare Co. stock logo
NHC
National HealthCare
56.44%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%

Insider Ownership

CompanyInsider Ownership
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
1.70%
Celcuity Inc. stock logo
CELC
Celcuity
15.77%
National HealthCare Co. stock logo
NHC
National HealthCare
14.97%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ardent Health Partners, LLC stock logo
ARDT
Ardent Health Partners
24,200143.04 millionN/AOptionable
Celcuity Inc. stock logo
CELC
Celcuity
4037.87 million31.27 millionOptionable
National HealthCare Co. stock logo
NHC
National HealthCare
12,40015.46 million13.32 millionN/A
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million74.68 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ardent Health Partners stock logo

Ardent Health Partners NYSE:ARDT

$13.14 -0.41 (-3.03%)
Closing price 03:59 PM Eastern
Extended Trading
$13.15 +0.01 (+0.08%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Celcuity stock logo

Celcuity NASDAQ:CELC

$12.11 -0.45 (-3.58%)
Closing price 04:00 PM Eastern
Extended Trading
$11.54 -0.57 (-4.75%)
As of 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

National HealthCare stock logo

National HealthCare NYSE:NHC

$103.10 -1.46 (-1.40%)
As of 04:00 PM Eastern

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Progyny stock logo

Progyny NASDAQ:PGNY

$21.03 -0.52 (-2.41%)
Closing price 04:00 PM Eastern
Extended Trading
$20.97 -0.06 (-0.30%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.